In addition to regulating estrogen receptor-dependent gene expression, 17␤-estradiol (E 2 ) can directly influence intracellular signaling. In primary cultured cerebellar neurons, E 2 was previously shown to regulate growth and oncotic cell death via rapid stimulation of ERK1/2 signaling. Here we show that ERK1/2 signaling in the cerebellum of neonatal and mature rats was rapidly responsive to E 2 and during development to the environmental estrogen bisphenol A (BPA). In vivo dose-response analysis for each estrogenic compound was performed by brief (6-min) intracerebellar injection, followed by rapid fixation and phosphorylation-state-specific immunohistochemistry to quantitatively characterize changes in activated ERK1/2 (pERK) immunopositive cell numbers. Beginning on postnatal d 8, E 2 significantly influenced the number of pERK-positive cells in a cell-specific manner that was dependent on concentration and age but not sex. In cerebellar granule cells on postnatal d 10, E 2 or BPA increased pERKpositive cell numbers at low doses (10 ؊12 to 10 ؊10 M) and at higher (10 ؊7 to 10 ؊6 M) concentrations. Intermediate concentrations of either estrogenic compound did not modify basal ERK signaling. Rapid E 2 -induced increases in pERK immunoreactivity were specific to the ERK1/2 pathway as demonstrated by coinjection of the mitogen-activated, ERK-activating kinase (MEK)1/2 inhibitor U0126. Coadministration of BPA (10 ؊12 to 10 ؊10 M) with 10 ؊10 M E 2 dose-dependently inhibited rapid E 2 -induced ERK1/2 activation in developing cerebellar neurons. The ability of BPA to act as a highly potent E 2 mimetic and to also disrupt the rapid actions of E 2 at very low concentrations during cerebellar development highlights the potential low-dose impact of xenoestrogens on the developing brain. (Endocrinology 146: 5388 -5396, 2005) 
I
N THE BRAIN, 17␤-estradiol (E 2 ) regulates the ovarian cycle through the hypothalamo-pituitary system, influences sexual differentiation of the male brain, and directly affects the development and function of neurons and glia throughout the brain. Some, but not all, of the diverse actions of E 2 are mediated through the intracellular estrogen receptors ER␣ and ER␤ that act as transcriptional transactivators to regulate estrogen-responsive gene expression. As in other tissues, rapid actions of E 2 and chemicals with estrogen-like properties can also impact directly intracellular signaling in the brain (1) (2) (3) (4) .
The ERK1/2 are components of a MAPK signaling cascade that regulates a variety of important cellular events and in some cell types is rapidly responsive to E 2 (1) . These signaling intermediaries are expressed throughout the brain and play important roles in the regulation of neuronal proliferation, differentiation, viability, and postsynaptic information processing (5) (6) (7) (8) (9) . In the brain, rapidly acting estrogen-dependent mechanisms can facilitate ERK-dependent enhancement of hippocampal long-term potentiation (10) , protect primary cortical and hippocampal neurons from excitotoxicity (11, 12) , influence midbrain dopaminergic neuron and astrocyte function (13, 14) , and impact the development and viability of cerebellar neurons (15) .
Xenoestrogens are man-made environmental contaminants defined by their ability to act synergistically with or antagonize the activity of endogenous estradiol. The prototypical xenoestrogen bisphenol A (BPA) is structurally similar to the potent nonsteroidal synthetic estrogen diethylstilbestrol, can bind ERs with low affinity to mimic or block some actions of endogenous E 2 , and has been linked to certain hormone-responsive cancers (16 -19) . Along with acting through the ERs to influence E 2 -responsive gene expression, some environmental estrogens can also activate rapid intracellular signaling mechanisms that are normally activated by endogenous E 2 (20 -23) . BPA is produced in large amounts for use as a monomer in the production of polycarbonate plastics and epoxide resins that are used as coatings for food cans and plastic packaging, dental sealants, and water pipes. As a result, there is extensive human exposure to BPA that has been estimated to range from 2-20 g/kg/d (24) . During pregnancy, BPA is detectable in maternal (0.3-18.9 ng/ml) and fetal (0.2-9.2 ng/ml) serum, demonstrating ready passage of BPA through the placenta (25) . Compared with other tissues, BPA is concentrated approximately 5-fold in amniotic fluid during early pregnancy, further indicating significant fetal exposure during important periods of human development (26) . The levels of BPA to which adult and fetal humans are exposed negatively impacts reproductive func-tion, neurodevelopment, and hippocampal synapse formation in rodents (27) (28) (29) (30) (31) (32) . However, little is known about the impact of environmental estrogens on rapid estrogen-induced signaling during nervous system development.
Unlike more widely studied E 2 -sensitive neurons from the forebrain (e.g. the telencephalonic cereberal cortex and hippocampus and the diencephalonic thalamus and hypothalamus), the hindbrain developmental lineage of the metencephalon-derived cerebellum is unrelated to reproductive endocrine function of the brain. Because of the disconnect between the sexual/reproductive actions of E 2 , and current understanding of cerebellar development and function, the idea that the cerebellum is a primary E 2 -sensitive brain region has remained controversial. This controversy persists despite numerous in vitro and in vivo studies that clearly demonstrate ERs are expressed and functional in the developing and adult cerebellum (15, (33) (34) (35) (36) (37) (38) (39) (40) (41) (42) (43) (44) (45) . Because there is little evidence supporting sexual differentiation of the cerebellum, we reasoned that during cerebellar development, E 2 is involved with general developmental effects that represent a subset of E 2 responses mediated through regulation of growth factor-like intracellular signaling. With the recent elucidation of the pattern of ERK activity during cerebellar ontogeny (9), we are now able to test the hypothesis that E 2 rapidly modulates in vivo ERK signaling in the cerebellum and that low doses of the xenoestrogen BPA impact normal E 2 -regulated signaling functions in the developing brain. In the present study we examined the rapid effects that E 2 and BPA, alone or in combination, have on ERK1/2 signaling in cells of the developing cerebellar cortex in vivo. Analysis of our results revealed that E 2 and BPA, at low and comparable concentrations, could rapidly modulate ERK signaling in a dose-dependent fashion. Additionally, BPA was found to act as a highly potent disruptor of rapid E 2 -induced actions in the developing cerebellum. Those results suggest that low doses of BPA, and potentially other environmental estrogens, alter rapid actions of endogenous estrogens with potentially negative consequences to the developing brain.
Materials and Methods

Animals, surgery, and treatments
All animal procedures were done in accordance with protocols approved by the University of Cincinnati Institutional Animal Care and Use Committee and followed National Institutes of Health guidelines. Equal numbers of male and female Sprague-Dawley rats of various ages [postnatal d 4 (P4) to P19] and adult rats (250 -300 g) were used for this study. For each age, all control or experimental groups contained from four to nine animals. Pups were kept with their mothers and maintained under standard laboratory conditions. Animals were anesthetized with a mixture of ketamine (P4 -12 animals, 230 mg/kg sc; P15-16 animals, 215 mg/kg sc; adults, 200 mg/kg im) and 6.6 mg/kg xylazine. As described previously, pilot studies indicated that anesthesia did not influence phospho-ERK immunoreactivity (pERK-IR) in the cerebellum of the anesthetized animals (9) .
The heads of anesthetized animals were secured in a stereotaxic apparatus; neonatal animals were fixed in the stereotaxic apparatus equipped with a small animal adaptor (46) . Fasciae and cervical musculature were dissected to expose the occipital bone, which was separated from the surrounding bones of the calvaria dorsally along the interparietooccipital suture and bilaterally along the dorsal half of the temporooccipital suture. Bilateral separation lines were directed ventromedially crossing the dorsal condyllar fossa to the dorsal arch of the foramen magnum just above the occipital condyles. The occipital bone was separated from the first cervical vertebra with a transverse cut of the dorsal atlantooccipital membrane. The occipital bone was removed and the dura mater and arachnoidea were cut along the midsagittal plane exposing the dorsocaudal cerebellar surface. In adults, injections were made through a small hole drilled into the midline dorsal surface of the skull 12.3 mm behind the bregma.
With a 5-l Hamilton syringe attached to the stereotaxic apparatus, injections were directed into cerebellar folia 6 and 7. The needle was vertically lowered in the midsagittal plane to the suprafastigial region and pulled back 0.5 mm to create a cavity for the injected material. Cyclodextrin-encapsulated 17␤-estradiol or BPA (Sigma Chemical Co., St. Louis, MO) at each concentration (10 Ϫ12 to 10 Ϫ6 m) was injected (3 l) into the cerebella of P4 -10 animals, with older animals receiving 5 l. For each age, noninjected, mock-injected, and equal molar vehicle-injected animals (2-hydroxypropyl-␤-cyclodextrin in PBS or PBS/0.001% dimethylsulfoxide; Sigma) were used as controls. Estradiol was also coinjected with either BPA or the selective MEK inhibitor UO126 (1 m; Promega, Madison, WI). Six minutes after the initiation of injection, animals were rapidly decapitated and brains dissected and placed in ice-cold fixative [4% paraformaldehyde/3% acrolein in 0.1 m phosphate buffer (PB), pH 7.4]. Brains were fixed overnight and postfixed in 4% paraformaldehyde until tissue processing.
Immunohistochemistry
Immunohistochemical protocols for staining cerebellar sections with rabbit anti-phospho-p44/42 MAPK antiserum (1:400) (catalog no. 9101; Cell Signaling Technology, Inc., Beverly, MA) were described previously (9) . Briefly, 40-m-thick sections were cut and rinsed three times for 10 min in PB. To eliminate unbound aldehydes, sections were incubated for 20 min in 1% sodium borohydride, followed by six 7-min washes in PB. Free-floating sections were incubated overnight with primary antiserum at 4 C and then extensively washed with PB. Bound antibodies were visualized with nickel-intensified diaminobenzidine by the avidin-biotin peroxidase complex method following standard protocols (Vectastain ABC Kit; Vector Laboratories, Burlingame, CA). Digital images were captured with a SpotRT (Bridgewater, NJ) CCD camera using Image Pro Plus version 4.5 software. Final graphics were generated and labeled using Photoshop version 6.01 (Adobe, San Jose, CA) software.
Quantitative analysis
In neonatal animals, E 2 /BPA-induced changes in pERK-IR were generally confined to the internal granular layer (IGL) and corpus medullare of the posterior lobe; therefore, folium IX of the cerebellum was selected for OD measurements. Gray-scale digital images of one midsagittal section, at the mediolateral level of the injection site, per animal were analyzed using Image Pro Plus version 4.5. To correct for possible fluctuations in light intensity during image capture, and to ensure the accuracy of measurements, image brightness was normalized to background levels. The area of the IGL, including the corpus medullare, was outlined in folium IX, and the mean OD was determined with Image Pro Plus version 4.5 using Area/Mean OD function yielding OD values normalized to the calculated area expressed as arbitrary OD units. Preliminary studies comparing manual counts of immunopositive cells with OD measurements revealed a 1:1 correlation between the calculated OD and immunopositive cell number. Statistical analysis and graphic representation of data were prepared using Prism version 4.0 (GraphPad) software. The level of significance between groups was determined by one-way ANOVA with posttest comparison using Tukey-Kramer multiple comparison test. At P10, the density values for the different treatments (E 2 and BPA) and concentrations were analyzed for significant differences by a two-factor ANOVA with specific group differences identified using Bonferroni's posttest for multiple comparison (P Ͻ 0.05). A quantitative assessment of E 2 's action was not performed for adults because of the highly focal nature of the observed changes in pERK-IR.
Analysis and fitting of E 2 and BPA data
The biphasic effects of E 2 and BPA at the low-dose concentration range (10 Ϫ12 to 10 Ϫ9 m) were assumed to act at two binding sites, one stimulatory with a high affinity and one with a lower affinity that inhibits the effect of the first site. Based on the observed similarity in effect at each dose and the fairly low resolution of the experiments, it was also assumed that neither of the two sites distinguishes between E 2 and BPA. Thus, data points were fit with the Hill-type equation:
where [C] is the concentration of the ligand. A best fit of the equation to the data resulted from setting the maximum effect of the stimulatory site (maximal stimulation) at 110%, with resulting values of 0.4 and 2 obtained for the stimulatory and the inhibitory Hill coefficients (H 1 and H 2 ), respectively. Under these conditions, EC 50Stim and EC 50Inhib were determined as 8 pm and 0.4 nm, respectively.
Primary cultures of cerebellar neurons
Primary cerebellar granule cell cultures were prepared from male or female Sprague-Dawley rats at P7-9 and were maintained under serumfree conditions without the addition of exogenous steroids as previously described (15, 47) . Quantitative Western blot analysis of rapid BPAinduced ERK phosphorylation in these primary cultures of cerebellar cells followed previously published protocols (15) . Presented Western blot results are representative of four independent BPA dose-response experiments.
Results
At all ages, the cellular localization and individual variability of pERK-IR in the cerebella of all controls were identical to that described previously (9) . On P4 and P6, E 2 exposure did not influence the density of pERK-immunopositive neurons or glia during this early period of postnatal development (not shown).
At P8, injection of E 2 at 10 Ϫ12 to 10 Ϫ11 m and 10 Ϫ7 to 10 Ϫ6 m significantly increased pERK-immunopositive cell numbers in the IGL and the corpus medullare of the posterior cerebellar lobe. The effects of E 2 were most pronounced in folium IX (Fig. 1, A-D) . The results of the in vivo E 2 doseresponse analysis indicated a bimodal dose dependency with no influence on ERK signaling at intermediate concentrations of E 2 (e.g. Fig. 2A ). These results were reminiscent of previous in vitro dose-response results obtained with a homogenous population of primary cultured cerebellar granule cell neurons (15) .
In the cerebellum at P10, baseline levels of pERK-IR are normally increased (Fig. 1, A and E) (9) . E 2 injection further stimulated ERK phosphorylation in granule cells in the IGL and in cells of the corpus medullare (Fig. 1, E-H) . The sensitivity to E 2 exposure was spread to all lobes of the cerebellar cortex (Fig. 1, F and H, arrowheads) . A bimodel dose response to E 2 was again observed with 10 Ϫ10 and 10 Ϫ6 m being most efficacious at increasing pERK-IR cells numbers (Fig. 2B) . In cerebella exposed to intermediate concentrations of E 2 (10 Ϫ9 to 10 Ϫ8 m), the pattern and density of pERK-immunostained cells was comparable to controls (Fig. 2B) . Coinjection of 10
Ϫ10 m E 2 with the selective MEK inhibitor U0126 completely blocked rapid E 2 -dependent increases in pERK-IR cell numbers (Fig. 3, A , B, and G).
At P10, the effects of BPA on pERK-positive cerebellar cells were very similar to those induced by E 2 (Fig. 3, D-F) . Comparison of the in vivo dose-response curves for E 2 -and BPAmediated effects on pERK-IR cell numbers reveals a striking similarity between the bimodal dose dependency of E 2 and BPA (Fig. 3G) . At low doses, E 2 and BPA were equally potent and efficacious. The calculated EC 50 for their low-dose effects were 7.46 and 3.25 pm, respectively. The low-dose data for E 2 and BPA (10 Ϫ12 to 10 Ϫ9 m) fit well to two Hill-type com- ponents. The EC 50 value for the stimulatory component was 8 pm, and the EC 50 of the second inhibitory component was 0.4 nm (Fig. 3H) . The Hill coefficients for the stimulatory and inhibitory components were 0.4 and 2, respectively. At high concentrations, BPA was significantly less efficacious (Fig.   3G) , with average high-dose EC 50 values of 126 nm for E 2 and 539 nm for BPA.
The ability of BPA to inhibit rapid E 2 actions was tested by coinjection of different concentrations of BPA with 10 Ϫ10 m E 2 . This dose inhibition analysis revealed that essentially all rapid estrogenic effects of either estrogenic compound were blocked by an equal molar mixture of the maximally active concentrations (10 Ϫ10 m) of E 2 and BPA (Fig. 3, C and H) . This blockade was also observed with a 1:1 mixture of 10 Ϫ11 m E 2 and BPA (not shown). Whereas 10 Ϫ12 m of either BPA or E 2 alone was able to significantly increase levels of pERK-IR (Fig. 3G) , when presented as a mixture, 10 Ϫ12 m BPA was able to block approximately 50% the pERK-stimulating activity of 10 Ϫ10 m E 2 (Fig. 3H) . The ability of BPA to stimulate ERK signaling in cerebellar granule cells was confirmed by quantitative Western blot analysis of pERK levels in primary cultures of neonatal cerebellar granule cells (Fig. 4, A and B) . Compared with control, significant increases in levels of pERK1 and pERK2 were detected after 10-min exposures to 10 Ϫ10 , 10 Ϫ8 , and 10 Ϫ6 m BPA. In response to 10 Ϫ10 m BPA, the 4.2-fold pERK1 stimulation relative to vehicle-treated control was significantly greater than the 2.75-fold induction by 10 Ϫ8 m BPA. Similar bimodality in efficacy was not detectable for ERK2 activation, suggesting that BPA may differentially influence rapid ERK1 and ERK2 signaling.
On P12, rather than stimulating ERK signaling, in vivo E 2 decreased the number of pERK-IR cells in a bimodel dosespecific fashion (Figs. 1, I -L, and 2C). The decrease in pERK-IR was most apparent at 10
Ϫ6 m E 2 (Figs. 1L, 2C , and 5A) with smaller, yet significant decreases observed with 10 Ϫ11 , 10 Ϫ10 , and 10 Ϫ7 m E 2 (Fig. 2C) . In contrast to the overall reduction in the number of pERK-immunopositive cells at P12, E 2 stimulated nuclear localized pERK-IR in scattered Golgi-like neurons (Fig. 5A, black arrowheads) . In interneurons between P12 and P19, the pERK-stimulating effects of E 2 progressively increased to the levels observed in adults (not shown).
In the adult cerebellum, the effects of E 2 injection were restricted to the injected folium and were strikingly cell type specific. Exposure to 10 Ϫ10 and 10 Ϫ6 m E 2 -induced ERK phosphorylation in clusters of granule cells (Fig. 1N, inset) , Golgilike interneurons, basket cells, stellate cells, globular Lugarolike cells (48) (Fig. 1, N and P, inset, and Fig. 5 ), and focally in clusters of Bergmann glia (Fig. 1P) . In contrast to the pERK-stimulatory effects, E 2 eliminated pERK-IR from the axon hillock and ventrolateral perikaryal regions of Purkinje cells, an effect not seen outside of the injected cerebellar folium (Fig. 5, B1-B2 ).
Discussion
Previous studies defining the cell-specific pattern of ER␤ expression during cerebellar development and analysis of the rapid actions of E 2 in primary cultures of developing cerebellar neurons clearly demonstrate that the cerebellum is an estrogen-sensitive brain region (15, 49, 50) . In developing granule cell precursors (GCPs), E 2 regulates ERK1/2 activity via a membrane-associated mechanism that, when activated in the absence of classical ER-responsive effects, resulted in Values indicate the mean OD normalized to the area of folium 9 from a single section for each cerebellum within a group; error bars represent the SEM. At least six animals were treated and analyzed per treatment group. The level of significance between values obtained for each treatment group was assessed with a one-way ANOVA. The level of significance between the control values and individual treatment groups are indicated: *, P Ͻ 0.05; **, P Ͻ 0.01; ***, P Ͻ 0.001.
decreased GCP mitosis and oncotic cell death (15) . It was demonstrated here that a wide range of physiologically important concentrations of E 2 and the prototypical xenoestrogen BPA could rapidly influence the phosphorylation state of ERK1/2 in the developing and mature cerebellum in vivo. Beginning at P8, the influence of these estrogens was detected in both males and females and varied during development. The dose dependency of these effects was similar to the rapid E 2 -mediated actions characterized in primary cultured GCPs (15) .
Many of the actions of E 2 are mediated through the transcriptional activity of the intracellular ERs; however, E 2 and estrogen-like chemicals can also rapidly influence intracellular signaling independent of classical ER-mediated transcriptional mechanisms (1, 11, 15, (51) (52) (53) . Throughout the developing brain, activation of the ERK1/2 signaling cascade is involved in proliferation, differentiation, and neuronal plasticity (54 -57) . The impact of these estrogenic compounds on ERK signaling in the developing cerebellum is likely to influence cerebellar development and neurotransmission in the mature cerebellum. Because rapid signaling actions of E 2 are necessary for full expression of ER-mediated transactivation of estrogen-responsive gene expression (58), the ability of BPA to influence the rapid actions of endogenous E 2 in the cerebellum at concentrations in the range of human fetal exposures (25) has especially profound implications regarding the ability of endocrine disrupting chemicals to modify the normal neurodevelopmental actions of endogenous estrogens.
Experiments using systemic injection of high concentrations of E 2 into ␣ERKO, ␤ERKO, and the double ␣␤ERKO knockout mice demonstrated that rapidly E 2 -induced cAMP signaling was dependent on the ERs normally expressed in a given brain region (59) . In the medial preoptic nucleus, a brain region where ER␣ and ER␤ are coexpressed (60, 61) , E 2 could also rapidly stimulate ERK signaling, with the loss of either ER blocking the rapid E 2 -induced increases in ERK phosphorylation observed in wild-type medial preoptic nu- cleus cells (59) . Given this critical dependence on classical ER expression in rapidly responsive regions of the mouse brain, it is likely that in the cerebellum, where only ER␤ is expressed at any appreciable level (39 -41, 50) , the rapid effects of E 2 on ERK phosphorylation are mediated through ER␤. Additional evidence suggesting that ER␤ mediates rapid E 2 actions in the cerebellum is the close correlation between the ontogeny of ER␤ expression in specific cell types (50) and the onset of detectable rapid actions of E 2 on pERK-IR in those cells.
The effect of ontogeny on rapid actions of E 2 and BPA
In the developing rat cerebellum, E 2 rapidly modulated ERK phosphorylation after the first postnatal week. At P8, E 2 increased the number of pERK-IR cells in the posterior lobe of the cerebellum. During cerebellar development, P8 is marked by a slowing from peak granule cell mitosis, the settlement of postmigratory granule cell neurons, and the establishment of mossy fiber afferents on the settled granule cells, processes that occur first in posterior cerebellar folia (62, 63) . The established excitatory mossy fiber synapses on granule neurons must undergo further maturation before becoming fully functional around P12, and inhibitory Golgi cell efferents are established on granule cells only after P11 (63) . Thus, during the time E 2 stimulates pERK signaling in granule cells, the neural connectivity of granule cells is composed solely of immature excitatory synapses. Because both E 2 and ERK signaling play important functional roles in the regulation of glutamatergic neurotransmission, excitatory synaptic dynamics, and assembly of the postsynaptic cytoskeleton (64), it is possible that the observed E 2 -induced increases in the number of pERK-IR cells reflect transient involvement with modulating the maturation and/or activity of immature excitatory synapses. Intracerebellar injection of E 2 at P12 rapidly decreased the number of pERK1/2-IR granule cells and stimulated pERK-IR in Golgi-like inhibitory neurons. Developmentally at P12, the maturation of granule cell excitatory afferents is completed. In contrast to earlier times during development, abundant inhibitory Golgi terminals are established on granule cell neurons and on the Golgi cells themselves. The correlation between formation of this inhibitory network and E 2 decreasing the number of pERK-IR granule cells suggests that increased inhibitory synaptic transmission plays a cellspecific role in regulating the rapid responsiveness to estrogens in excitatory granule cells and Golgi interneurons. Although the nature of the developmental cues responsible for the difference in granule cell responsiveness are unknown, in maturing granule cells, between P8 and P12, there is a developmental switch in the estrogenic signaling mechanism linking the activated E 2 /ER complex to the ERK signaling cascade that results in blockade of baseline ERK signaling upstream of ERK1/2 and/or increased phosphatase activity in response to E 2 . At the level of ERK1/2, the result of those changes is an alteration in the balance between E 2 -induced kinase and dephosphorylating activities on the ERK signaling cascade.
At later times during postnatal cerebellar development, the effect of E 2 on pERK signaling became progressively more adult-like. In the cerebellar cortex of adult rats, E 2 activated the ERK pathway in inhibitory interneurons (stellate-, basket-, Lugaro-, and Golgi-like neurons) that are differentially responsible for the final shaping of Purkinje cell function. Stellate cells form inhibitory synapses on the stem of Purkinje cell dendritic branches, which selectively isolates dendritic branch excitation from the soma of Purkinje cells. Basket neurons block Purkinje cell output at the ventrolateral soma and adjacent axon hillock area of Purkinje cells, whereas Lugaro cells terminate on stellate, basket, and Golgi neurons (63) . To synchronize their function, these three types of inhibitory cerebellar neurons synapse with each other, forming an intrinsic inhibitory network. Because E 2 activates the ERK pathway in these inhibitory interneurons but eliminates pERK-IR from the axon hillock area of Purkinje cells, it is possible that E 2 activation of ERK signaling in these interneurons is reflected in the dephosphorylation of pERK in Purkinje cells. Additional studies are underway to determine the changing functional role of E 2 -modulated ERK activation in cerebellar neurotransmission and plasticity.
Pharmacology and mechanism of rapid actions of E 2 and BPA
The concentration-response data for rapid ERK actions of E 2 and BPA in the cerebellum resulted in distinctly bimodal dose-response curves that were characterized by an inverted U-shaped low-dose effect from 10 Ϫ12 to 10 Ϫ10 m, and a highdose effect at 10 Ϫ7 to 10 Ϫ6 m. Such atypical inverted U-shaped and bimodal dose-response curves describing the actions of hormones have begun to receive more widespread appreciation, with the differential actions that low and high concentrations and mixtures of estrogenic compounds have on the growth of the prostrate and breast cancer cells standing out as well known examples (65-67). As asserted previously (15) , the differences between the efficacy of BPA and E 2 at the high range, a distinction not apparent at low concentrations, suggest that the rapid ERK-signaling effects of low and high doses of these estrogens are mediated through different mechanisms.
The mechanisms responsible for the observed low-dose inverted U-shaped dose dependency of rapid ERK signaling in cerebellar neurons are unknown. However, if the rapid actions of E 2 are mediated through ER␤1 (K d for E 2 , 0.14 nm) (68), the primary ER␤ isoform expressed in the cerebellum (49) , some of the pharmacology underlying E 2 's low-dose effects can be explained simply by the fact that detectable rapid effects, like most hormone actions, occur at agonist concentrations well below those necessary to saturate the available receptors. However, the relative binding affinity of BPA at ER␤1 is approximately 15 times lower than for E 2 (68) . The ability of BPA to act as an equally potent agonist of rapid ERK phosphorylation and to inhibit the rapid actions of E 2 at very low concentrations is inconsistent with rapid activation of ERK1/2 being dependent simply on the occupancy of the primary ER␤1 ligand-binding site. Furthermore, the lack of responsiveness to E 2 or BPA at concentrations above 10
Ϫ10
m cannot be explained by increased occupancy and saturation of the ER␤ ligand-binding site alone. The finding that rapid low-dose agonist activity of both BPA and E 2 were completely blocked when each was presented in a 1:1 mixture suggests that E 2 and BPA are acting in an even more complicated fashion.
The pharmacological characteristics of the rapid low-dose agonist actions and the inhibitory actions of E 2 and BPA suggest a model in which the rapid-acting ER complex contains a high-affinity (picomolar) stimulatory binding site and a lower-affinity (nanomolar) inhibitory binding site. The resulting concentration-response data fit well with a Hill-type equation that assumed a high-affinity stimulatory binding site and a lower-affinity site that inhibited the effect of the first site (Fig. 3H) . The resulting stimulatory and the inhibitory Hill coefficients were 0.4 and 2, respectively. Because the Hill coefficient gives a quantitative measure of the degree of cooperativity between binding sites, a Hill coefficient of 0.4 for the low-dose ERK-stimulatory actions is suggestive of negative cooperativity. The existence of multiple intramolecular ligand-binding sites within the ligand-binding domain of classical nuclear ERs is supported by studies that have identified two tamoxifen-binding sites in ER␣ (69, 70) and by the identification of a second E 2 -binding site within the ligand-binding domain of both ER␣ and ER␤ (71, 72) .
To explain the paradoxical ability of 1 pm BPA to stimulate ERK signaling in the absence of E 2 and to also disrupt the same rapid action of E 2 when presented in a mixture, it is proposed that there exists an additional high-affinity BPAbinding site that becomes available only upon ligand binding at the high-affinity site of the rapid ERK-stimulating receptor. Binding of BPA, or lower-affinity E 2 binding, at this additional site stimulates an inhibitory activity. Based on our recent finding that along with rapidly stimulating ERK phosphorylation, E 2 also rapidly stimulates a protein phosphatase 2A-like ERK-dephosphorylating activity in cerebellar granule cells (73) , it is proposed that binding of E 2 at the highaffinity site results in conformational changes to reveal a latent intermolecular BPA-binding site. The binding of BPA at that site acts to stimulate phosphatase activity via an independent signaling cascade. Although the proposed model represents a simplified working hypothesis, it is important to note that numerous factors such as the coexpression of multiple isoforms of ER␤ (e.g. ER␤1 and ER␤2) with differences in ligand-binding affinities, the potential influence of ER␤ homodimers and ER␤1/␤2 heterodimers, posttranslational modifications of the receptors, localization of the receptor at the membrane, and the changeable nature of the receptor signaling complex all likely contribute to the complex pharmacological properties of the rapid actions of these estrogens.
In summary, we showed that E 2 was able to rapidly regulate ERK signaling in the developing cerebellum in vivo and that there are cell-specific developmental changes in the sensitivity of excitatory and inhibitory neurons to the rapid effects of estrogens. The ability of the endocrine-disrupting chemical BPA to mimic and also inhibit the rapid actions of E 2 highlights the potential for environmentally relevant concentrations of xenoestrogens to adversely effect development and function throughout brain.
